Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Trial Comparing Effects of Xyrem Taken Orally and Modafinil With Placebo in Treating Daytime Sleepiness in Narcolepsy

ClinicalTrials.gov ID: NCT00066170

Public ClinicalTrials.gov record NCT00066170. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 20, 2026, 6:13 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Randomized, Double-Blind, Double-Dummy, Placebo-Controlled, Parallel-Group, Multi-Center Trial Comparing the Effects of Orally Administered Xyrem (Sodium Oxybate) and Modafinil With Placebo in Treatment of Daytime Sleepiness in Narcolepsy

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This study will be conducted as a randomized, double blind, double-dummy, placebo-controlled, parallel-group trial in patients diagnosed with narcolepsy. Volunteers for this trial will be required to make 5 visits over up to 14 weeks to a participating expert physician practitioner for various sleep and narcolepsy evaluations and diaries will also be collected. Participants will take assigned medications during the course of the trial. Subjects will have a 25% probability of receiving placebo for both drugs (modafinil and Xyrem). All subject volunteers must meet criteria for narcolepsy and have evidence of daytime sleepiness. Patients will not incur any personal medical expenses due to participation in this trial. The sponsor is covering all visit costs not covered by insurance and there are some funds for patient expenses such as travel.

Study identification

NCT ID
NCT00066170
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Jazz Pharmaceuticals
Industry
Enrollment
231 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 2003 (Type not available)
Primary completion
Jul 2004 (Actual)
Completion
Nov 2004 (Actual)
Last update posted
Dec 29, 2011

2003 – 2004

United States locations

U.S. sites
36
U.S. states
18
U.S. cities
32
Facility City State ZIP Site status
Pulmonary Associates, PA Phoenix Arizona 85006 —
St. Jude Medical Center -- Sleep Disorders Institute Fullerton California 92835 —
Pacific Sleep Medicine Services, Inc. Los Angeles California 90048 —
Neuro-Therapeutics, Inc. Pasadena California 91105 —
Pacific Sleep Medicine Services, Inc. San Diego California 92121 —
Stanford Sleep Disorders Clinic Stanford California 94305 —
Clinical Research Group of St. Petersburg, Inc. St. Petersburg Florida 33707 —
Peoria Pulmonary Associates, Ltd Peoria Illinois 61603 —
The Center for Sleep and Wake Disorders/Midwest Neurology Danville Indiana 46122 —
Graves Gilbert Clinic Bowling Green Kentucky 42101 —
Community Research & Sleep Management Institute Crestview Hills Kentucky 41017 —
Chest Medicine Associates DBA -- Sleep Medicine Specialists Louisville Kentucky 40217 —
The Center for Sleep & Wake Disorders Chevy Chase Maryland 20815 —
Sleep Disorders Center -- Union Hospital of Cecil County Elkton Maryland 21921 —
Sleep Medicine Associates of Maryland Towson Maryland 21204 —
Henry Ford Hospital Detroit Michigan 48202 —
Washington University Sleep Center St Louis Missouri 63108 —
New Jersey Neuroscience Institute at JFK Medical Center Edison New Jersey 08818 —
Sleep Disorders Center of Rochester Rochester New York 14618 —
Strong Sleep Disorders Center Rochester New York 14618 —
Raleigh Neurology Associates Raleigh North Carolina 27607 —
ALL-TRIALS Clinical Research, LLC -- Summit Sleep Disorder Winston-Salem North Carolina 27103 —
Cincinnati Clinic & Sleep Management Institute Cincinnati Ohio 45219 —
Community Research Management Associates,Inc. Cincinnati Ohio 45219 —
CSC Research -- Grove City Sleep Diagnostic Center Grove City Ohio 43123 —
Lehigh Valley Hospital Sleep Disorders Center Allentown Pennsylvania 18105 —
Capital Region Sleep Disorder Center Carlisle Pennsylvania 17013 —
Center for Sleep Medicine Lafayette Hill Pennsylvania 19444 —
Lowcountry Lung and Critical Care, PA Charleston South Carolina 29406-7108 —
SleepMed of South Carolina Columbia South Carolina 29220 —
SDHRF Clinical Research Center Sioux Falls South Dakota 57104 —
Sioux Valley Clinic -- Pulmonary Sioux Falls South Dakota 57105 —
Sleep Disorders Center Sioux Falls South Dakota 57105 —
Bhupesh Dihenia, MD Lubbock Texas 79410 —
SLEEP WALKER -- Sleep Disorders Center & Neurodiagnostics--Lung Diagnostics, Ltd. San Antonio Texas 78229 —
Vermont Medical Sleep Disorders Center, Inc. Essex Junction Vermont 05452 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 4 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00066170, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Dec 29, 2011 · Synced Oct 20, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00066170 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →